NCT05526703View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy

PHASE3UnknownINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Essential Hypertension
Interventions
DRUG

D064, D701, placebo of D012

Experimental Group Subjects assigned to this group are treated with D064, D701, placebo of D012

DRUG

D012, placebo of D064, placebo of D701

Comparator Group Subjects assigned to this group are treated with D012, placebo of D064, placebo of D701

Trial Locations (1)

"ASI

RECRUITING

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT05526703 - Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy | Biotech Hunter | Biotech Hunter